Literature DB >> 4317348

Immunodiffusion analysis of Yaba poxvirus structural and associated antigens.

R G Olsen, D S Yohn.   

Abstract

Yaba poxvirus virions were extracted and purified from Rhesus monkey tumors. A saline-soluble virion fraction (Y-xp), obtained by mechanical fractionation of purified virions with an X-press, contained seven components in acrylamide gel electrophoresis; five of these components were reactive in immunodiffusion with whole virion and Y-xp antisera produced in rabbits and monkeys. The saline-insoluble residue remaining after X-press treatment was hydrolyzed with sodium dodecyl sulfate, urea, and 2-mercaptoethanol (SUM). This fraction, Y-sum, contained five components, four of which were demonstrable by immunodiffusion. There was no evidence of antigenic relationships between Y-xp and Y-sum antigens in immunodiffusion. In acrylamide gel electrophoresis, one Y-xp and one Y-sum component had similar mobilities. Y-xp but not Y-sum antisera contained viral-neutralizing antibodies. Virus-free saline extracts of Yaba tumor prepared with Genetron (YS) were essentially devoid of virion structural antigens. They failed to induce precipitating antibodies for virion antigens, were nonreactive in immunodiffusion with virion antisera, and gave low complement-fixation titers with virion antisera. Yaba virion antigens were recovered from the Genetron tumor sediment by SUM and alkaline hydrolysis. Antisera prepared to YS extracts gave a maximum of 17 precipitin lines in immunodiffusion with YS extracts; none was identified as a virion structural antigen. Saline extracts of tumor prepared without Genetron contained immunogenic amounts of 5 virion antigens and 12 to 14 associated antigens. Animals immunized with infected cell culture extracts (virus-free) formed antibodies to six to seven virion antigens. The implications of using extracts of Yaba poxvirus-infected tissues in complement-fixation tests to measure virion antibodies were discussed.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4317348      PMCID: PMC375989     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Immunologic response of monkeys to aerosols of Yaba virus.

Authors:  L G Wolfe; A Adler; R A Griesemer
Journal:  J Natl Cancer Inst       Date:  1968-11       Impact factor: 13.506

2.  Some physiochemical properties of Yaba poxvirus deoxyribonucleic acid.

Authors:  D S Yohn; J F Gallagher
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

3.  Yaba tumor virus. I. Studies on pathogenesis and immunity.

Authors:  A M Behbehani; C R Bolano; P S Kamitsuka; H A Wenner
Journal:  Proc Soc Exp Biol Med       Date:  1968-11

4.  Titration and extensive serial passages of Yaba virus in vitro.

Authors:  Y Tsuchiya; I Tagaya; T Tsuruhara
Journal:  Jpn J Microbiol       Date:  1969-03

5.  The fine structure of the Yaba monkey tumor poxvirus.

Authors:  E De Harven; D S Yohn
Journal:  Cancer Res       Date:  1966-05       Impact factor: 12.701

6.  Yaba tumor poxvirus synthesis in vitro. I. Cytopathological, histochemical, and immunofluorescent studies.

Authors:  D S Yohn; V A Haendiges; J T Grace
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

7.  In vitro characteristics of a poxvirus isolated from rhesus monkeys.

Authors:  A H Nicholas; W P McNulty
Journal:  Nature       Date:  1968-02-24       Impact factor: 49.962

8.  Immunoprecipitating factors of vaccinia virus.

Authors:  J Marquardt; S E Holm; E Lycke
Journal:  Virology       Date:  1965-10       Impact factor: 3.616

9.  Yaba tumor poxvirus synthesis in vitro. II. Adsorption, inactivation, and assay studies.

Authors:  D S Yohn; F R Marmol; V A Haendiges; J T Grace
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

10.  Soluble antigens of vaccinia-infected mammalian cells. I. Separation of virus-induced soluble antigens into two classes on the basis of physical characteristics.

Authors:  G H Cohen; W C Wilcox
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

View more
  8 in total

1.  The protective antigens of equine herpesvirus type 1.

Authors:  G Papp-Vid; J B Derbyshire
Journal:  Can J Comp Med       Date:  1978-04

2.  Further studies on the development of Yaba poxvirus in cell culture.

Authors:  T Tsuruhara; A Tsuruhara
Journal:  Arch Gesamte Virusforsch       Date:  1973

3.  Differences in clinical and convalescent-phase antibodies of Rhesus monkeys infected with monkey pox, tanapox, and Yaba poxviruses.

Authors:  R D Hall; R G Olsen; S P Pakes; D S Yohn
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

4.  Non-immunological precipitation of serum by sodium dodecyl sulfate in agar diffusion.

Authors:  C T Cho; K K Feng
Journal:  Appl Microbiol       Date:  1974-10

5.  Proteins of Yaba monkey tumor virus I. Structural proteins.

Authors:  T Fenger; H Rouhandeh
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

6.  Preparation and evaluation of a noninfectious monkey pox virus vaccine.

Authors:  R G Olsen; J R Blakeslee; L Mathes; J H Nakano
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

7.  Growth kinetics of Yaba tumor poxvirus after in vitro adaptation to cercopithecus kidney cells.

Authors:  D S Yohn; F R Marmol; R G Olsen
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

8.  Differences in acute and convalescent-phase antibodies of cats infected with feline picornaviruses.

Authors:  R G Olsen; D E Kahn; E A Hoover; N J Saxe; D S Yohn
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.